As revealed in the heatmap, the average AUC of EGFR.Sig ranked at the top of the published gene signatures (Figure 5D), which indicated a better ability of EGFR.Sig to predict the immunotherapy response, especially for the Zhao 2019 GBM cohort. This evidence concerns the gene EGFR and glioblastoma.